COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,442 Articles (22,835 medRxiv, 8,607 bioRxiv)

Most recent first Previous |  Page 873: Articles 8721-8730  | Next

Optimized production and fluorescent labelling of SARS-CoV-2 Virus-Like-Particles to study virus assembly and entry.
Muriaux, D., Gourdelier, M., Swain, J. M., Arone, C., Mouttou, A., Bracquemond, D., Merida, P., Saffarian, S., Lyonnais, S., Favard, C.
10.1101/2022.03.23.485575 — Posted: 2022-03-27
The Envelope Protein of SARS-CoV-2 Inhibits Viral Protein Synthesis and Infectivity of Human Immunodeficiency Virus type 1 (HIV-1)
Stephens, E. B., Henke, W., Polpitiya Arachchige, S., Waisner, H., Kalamvoki, M.
10.1101/2022.03.23.485576 — Posted: 2022-03-27
Antiviral roles of interferon regulatory factor (IRF)-1, 3 and 7 against human coronavirus infection
Xu, D., Duncan, J. K. S., Licursi, M., Gohda, J., Kawaguchi, Y., Hirasawa, K.
10.1101/2022.03.24.485591 — Posted: 2022-03-27
Inconsistent directions of change in case severity across successive SARS-CoV-2 variant waves suggests an unpredictable future
Pascall, D. J., Vink, E., Mollett, G., Blacow, R., Bulteel, N., Campbell, R., Campbell, A., Clifford, S., Davis, C., da Silva Filipe, A., Fjodorova, L., Forrest, R., Goldstein, E., Gunson, R., Haughney, J., Holden, M. T., Honour, P., Hughes, J., James, E., Lewis, T., McHugh, M., Onishi, Y., Parcell, B., Robertson, D. L., El Sakka, N., Shabaan, S., Shepherd, J. G., Smollett, K., Templeton, K., Wastnedge, E., Williams, T. C., Nyberg, T., Seaman, S. R., MacLean, O., Wilkie, C., Ray, S., The COVID-19 Genomics UK (COG-UK) consortium, , Thomson, E. C.
10.1101/2022.03.24.22272915 — Posted: 2022-03-27
Local CCL18 and CCL21 expand lung fibrovascular niches and recruit lymphocytes, leading to tertiary lymphoid structure formation in prolonged COVID-19
Mothes, R., Pascual Reguant, A., Koehler, R., Liebeskind, J., Liebheit, A., Bauherr, S., Dittmayer, C., Laue, M., von Manitius, R., Elezkurtaj, S., Durek, P., Heinrich, F., Heinz, G. A., Guerra, G. M., Obermayer, B., Meinhardt, J., Ihlow, J., Radke, J., Heppner, F. L., Enghard, P., Stockmann, H., Aschman, T., Schneider, J., Corman, V., Sander, L. E., Mashreghi, M.-F., Conrad, T., Hocke, A., Niesner, R. A., Radbruch, H., Hauser, A. E.
10.1101/2022.03.24.22272768 — Posted: 2022-03-27
Detection and prevalence of SARS-CoV-2 co-infections during the Omicron variant circulation, France, December 2021 - February 2022
Bal, A., Simon, B., Destras, G., Chalvignac, R., Semanas, Q., Oblette, A., Queromes, G., Fanget, R., Regue, H., Morfin, F., Valette, M., Lina, B., Josset, L.
10.1101/2022.03.24.22272871 — Posted: 2022-03-27
Serological Response to Three, Four and Five Doses of SARS-CoV-2 Vaccine in Kidney Transplant Recipients
Osmanodja, B., Ronicke, S., Budde, K., Jens, A., Hammett, C., Koch, N., Seelow, E., Waiser, J., Zukunft, B., Bachmann, F., Choi, M., Weber, U., Eberspächer, B., Hofmann, J., Grunow, F., Mikhailov, M., Liefeldt, L., Eckardt, K.-U., Halleck, F., Schrezenmeier, E.
10.1101/2022.03.23.22270017 — Posted: 2022-03-27
Epidemiologic Assessment of Pediatric Inflammatory Bowel Disease Presentation in NYC During COVID-19
Rosenbaum, J. E., Castro Ochoa, K., Hasan, F., Goldfarb, A., Tang, V., Tomer, G., Wallach, T.
10.1101/2022.03.23.22272167 — Posted: 2022-03-27
Monitoring of the SARS-CoV-2 Omicron BA.1/BA.2 variant transition in the Swedish population reveals higher viral quantity in BA.2 cases
Lentini, A., Pereira, A., Winqvist, O., Reinius, B.
10.1101/2022.03.26.22272984 — Posted: 2022-03-27
Analysis of humoral immunity against emerging SARS-CoV-2 variants: a population-based prevalence study in Yokohama, Japan
Goto, A., Miyakawa, K., Nakayama, I., Yagome, S., Xu, J., Kaneko, M., Ohtake, N., Kato, H., Ryo, A.
10.1101/2022.03.26.22272766 — Posted: 2022-03-27

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).